Nearly 30 million adults in the U.S. have obstructive sleep apnea (OSA)—and many don't even know it. If you've been waking up ...
Mount Sinai researchers have created an analytic tool using machine learning that can predict cardiovascular disease risk in ...
Central sleep apnea (CSA) is fundamentally different from obstructive sleep apnea (OSA). The former is characterized by ...
CPAP machines are gaining popularity due to increased public discussion and awareness of sleep apnea. Affordable at-home sleep tests are now available, making diagnosis more accessible than ...
Automatic transvenous phrenic nerve stimulation demonstrates high nightly use and therapy adherence in adults with central ...
Mount Sinai researchers have created an analytic tool using machine learning that can predict cardiovascular disease risk in patients with obstructive sleep apnea ...
Prefer Newsweek on Google to see more of our trusted coverage when you search. An epilepsy drug could be used to help people with sleep apnea, a new study has found. A European clinical trial found ...
An estimated 1 billion people between the ages of 30 and 69 across the globe suffer from sleep apnea, particularly ...
New research to be presented at this year's European Congress on Obesity (ECO 2026, Istanbul, Turkey, 12-15 May) shows that those living with obstructive sleep apnea (OSA) have a 71% higher risk of ...
Please provide your email address to receive an email when new articles are posted on . Transvenous phrenic nerve stimulation therapy was automatically delivered to a patient when three conditions ...